Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer
about
Prevention and treatment of bone fragility in cancer patientLipophilic bisphosphonates plus rapamycin: a deadly combination for KRAS-mutated lung adenocarcinomaPolyoxomolybdate Bisphosphonate Heterometallic Complexes: Synthesis, Structure, and Activity on a Breast Cancer Cell Line.BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.Bisphosphonates inactivate human EGFRs to exert antitumor actions.Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cellsMolecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory.Bisphosphonate use and the risk of endometrial cancer: a meta-analysis of observational studies.Bisphosphonates as potential adjuvants for patients with cancers of the digestive system.Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.Targeting Cancer Cells with a Bisphosphonate Prodrug.Zoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor.Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results.Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies.Bisphosphonate-Generated ATP-Analogs Inhibit Cell Signaling Pathways.Oral bisphosphonate use and lung cancer incidence among postmenopausal women.
P2860
Q26775765-3EB6D309-1578-4DB9-885C-A3C5D0FFDF5BQ28606634-085A8A24-AAF6-4914-BBA5-C2554E340D8FQ30971976-042196E7-9980-4B75-A45C-28BD608987A9Q33798713-50E47EF5-E7A3-43F8-B322-D379D28B9AE9Q34752876-0CD4E6F7-FC12-42FB-89F9-D2558B8C2EEFQ35043887-118FB8A3-9B56-4AA7-B1AF-2EB86125870BQ35828688-3DDE9D9A-7796-4676-8670-14EB1E641DFEQ35906092-B2C27427-4E87-4491-A76A-ABBEA9BC99C4Q36097627-0D1F6130-EFAA-42A8-A9D3-AAB4A1977644Q36471673-08E0E8A5-F7A0-436B-BA98-A98942B594E9Q36772192-5135B01F-8458-4672-9C17-82E276C687A8Q37694808-9B27C690-BDEF-413E-AD26-30D9B6054DA5Q38431717-235789F9-7263-490D-9D6E-63307AD4B2F3Q38736342-5D63E8B6-C9BC-4E0A-A07C-261D937C9C22Q38875042-3199CB43-3BE4-4298-A521-7DD810217927Q39138688-01B2B6CA-8211-48E2-9962-C2B66DD38D25Q42178728-5D94564D-77D1-40FB-9A13-45909B58F74DQ46416599-445613B3-FB93-4EBA-BD48-E44508896396Q48059346-4308698D-C289-4A28-9E05-9189CD69B2D9Q48148231-E028A383-2DD7-4FCC-AC76-E64C9688BBDFQ54978574-F0B486A9-01A5-4D5A-8F51-296AB8F353F6Q55237144-5E578D1A-33FF-44B0-A7E7-AD318F876CA1
P2860
Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@ast
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@en
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@nl
type
label
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@ast
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@en
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@nl
prefLabel
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@ast
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@en
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@nl
P2093
P2860
P50
P356
P1476
Repurposing of bisphosphonates ...... ll cell lung and breast cancer
@en
P2093
Agnes Stachnik
Alberta Zallone
Aneel K Aggarwal
Christoph Buettner
Jameel Iqbal
Jaya Sangodkar
Jianhua Li
Ling-Ling Zhu
Maria I New
P2860
P304
17995-18000
P356
10.1073/PNAS.1421422111
P407
P577
2014-12-01T00:00:00Z